Cargando…
Challenges to the development of vaccines to hepatitis C virus that elicit neutralizing antibodies
Despite 20 years of research, a vaccine to prevent hepatitis C virus (HCV) infection has not been developed. A vaccine to prevent HCV will need to induce broadly reactive immunity able to prevent infection by the 7 genetically and antigenically distinct genotypes circulating world-wide. HCV encodes...
Autor principal: | Drummer, Heidi E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080681/ https://www.ncbi.nlm.nih.gov/pubmed/25071742 http://dx.doi.org/10.3389/fmicb.2014.00329 |
Ejemplares similares
-
A pan‐genotype hepatitis C virus viral vector vaccine generates T cells and neutralizing antibodies in mice
por: Donnison, Timothy, et al.
Publicado: (2022) -
Hepatitis C Virus (HCV) Envelope Glycoproteins E1 and E2 Contain Reduced Cysteine Residues Essential for Virus Entry
por: Fraser, Johanna, et al.
Publicado: (2011) -
Bivalent vaccine platform based on Japanese encephalitis virus (JEV) elicits neutralizing antibodies against JEV and hepatitis C virus
por: Saga, Ryohei, et al.
Publicado: (2016) -
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
por: Ahmed, Yousuf, et al.
Publicado: (2017) -
The Neutralizing Antibody Response Elicited by Tembusu Virus Is Affected Dramatically by a Single Mutation in the Stem Region of the Envelope Protein
por: Lv, Junfeng, et al.
Publicado: (2020)